Tomo Yoshida
About Tomo Yoshida
Tomo Yoshida is a Project Manager II at Suvoda in Tokyo, Japan, where he has worked since 2021. He has a background in biochemistry and molecular biology from Kobe University and a Doctor of Science in plant molecular genetics from Yokohama City University.
Work at Suvoda
Tomo Yoshida has been employed at Suvoda as a Project Manager II since 2021. In this role, he contributes to the management of clinical trial technology projects. Suvoda is recognized for its expertise in complex therapeutic areas, including oncology, CNS, and rare diseases. The company has supported over 1000 clinical trials across 65 countries, showcasing its global reach and commitment to advancing clinical research.
Previous Experience at Astellas Pharma
Prior to his current position, Tomo Yoshida worked at Astellas Pharma Europe as a Senior Information Manager from 2016 to 2019. He also held the position of Associate Manager at Astellas Pharma in Tokyo from 2014 to 2020. His tenure at Astellas Pharma provided him with significant experience in the pharmaceutical industry, enhancing his skills in project management and information management.
Experience at Medidata Solutions
Tomo Yoshida worked as an Implementation Consultant at Medidata Solutions from 2012 to 2013. This role allowed him to gain valuable experience in clinical trial technology implementation, further developing his expertise in the field. His work at Medidata Solutions contributed to his understanding of the complexities involved in clinical trials.
Education and Expertise
Tomo Yoshida earned a Bachelor's degree in Biochemistry and Molecular Biology from Kobe University, studying from 1998 to 2002. He furthered his education at Yokohama City University, where he obtained a Doctor of Science degree in Plant Molecular Genetics from 2002 to 2007. His educational background provides a strong foundation for his work in clinical trials and project management.
Industry Impact
Tomo Yoshida is part of a company that maintains a Net Promoter Score (NPS) significantly higher than the technology industry average. This reflects the company's commitment to client satisfaction and its effectiveness in managing clinical trials. His involvement in such a high-performing organization underscores his role in advancing clinical trial technology.